AR058605A1 - Preparacion solida - Google Patents
Preparacion solidaInfo
- Publication number
- AR058605A1 AR058605A1 ARP060105709A ARP060105709A AR058605A1 AR 058605 A1 AR058605 A1 AR 058605A1 AR P060105709 A ARP060105709 A AR P060105709A AR P060105709 A ARP060105709 A AR P060105709A AR 058605 A1 AR058605 A1 AR 058605A1
- Authority
- AR
- Argentina
- Prior art keywords
- insulin sensitizer
- solid preparation
- active ingredient
- insulin
- sensitizer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente pretende proporcionar una preparacion solida que contiene un sensibilizante de insulina como por ejemplo pioglitazona, entre otros y un ingrediente activo distinto de un sensibilizante de insulina, como por ejemplo un secretagogo de insulina, y exhibe comportamiento de disolucion de un sensibilizante de insulina similar al de un sensibilizante de insulina proveniente de ôuna preparacion solida que solo contiene un sensibilizante de insulina como ingrediente activoö. La preparacion solida comprende ôuna parte que contiene partículas recubiertas en donde las partículas que contienen un sensibilizante de insulina están recubiertas con lactosa o un azucar alcoholö y ôuna parte que contiene un ingrediente activo distinto de un sensibilizante de insulina.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005370375 | 2005-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR058605A1 true AR058605A1 (es) | 2008-02-13 |
Family
ID=37951491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060105709A AR058605A1 (es) | 2005-12-22 | 2006-12-21 | Preparacion solida |
Country Status (24)
Country | Link |
---|---|
US (1) | US8071130B2 (es) |
EP (1) | EP1962811B1 (es) |
JP (1) | JP5179363B2 (es) |
KR (1) | KR20080080126A (es) |
CN (1) | CN101384251B (es) |
AR (1) | AR058605A1 (es) |
AU (1) | AU2006328328B2 (es) |
BR (1) | BRPI0620020A2 (es) |
CA (1) | CA2633149C (es) |
CR (1) | CR10032A (es) |
ES (1) | ES2576258T3 (es) |
GE (1) | GEP20115245B (es) |
HR (1) | HRP20160679T1 (es) |
IL (1) | IL191774A0 (es) |
MA (1) | MA30061B1 (es) |
MY (1) | MY149306A (es) |
NO (1) | NO20083104L (es) |
NZ (1) | NZ569071A (es) |
PE (1) | PE20110019A1 (es) |
RU (1) | RU2426530C2 (es) |
TW (1) | TWI384985B (es) |
UA (1) | UA91729C2 (es) |
WO (1) | WO2007072992A2 (es) |
ZA (1) | ZA200805147B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY146781A (en) | 2006-05-23 | 2012-09-28 | Takeda Pharmaceutical | Oral preparation comprising pioglitazone |
PL2107905T3 (pl) | 2007-02-01 | 2011-04-29 | Takeda Pharmaceuticals Co | Stały preparat zawierający alogliptynę i pioglitazon |
JP5242576B2 (ja) * | 2007-08-27 | 2013-07-24 | 旭化成ケミカルズ株式会社 | 結晶セルロース及び顆粒含有錠の製造方法 |
JP5658172B2 (ja) * | 2009-01-23 | 2015-01-21 | ハンミ・サイエンス・カンパニー・リミテッド | アムロジピン及びロサルタンを含む固形薬剤学的組成物及びその製造方法 |
EP2506835B1 (en) * | 2009-11-30 | 2019-06-12 | Adare Pharmaceuticals, Inc. | Compressible-coated pharmaceutical compositions and tablets and methods of manufacture |
CN101804056A (zh) * | 2010-04-16 | 2010-08-18 | 山东新华制药股份有限公司 | 盐酸吡格列酮、格列美脲的复方片剂及制备方法 |
JP2013538807A (ja) | 2010-09-01 | 2013-10-17 | ルピン・リミテッド | メトホルミンおよびピオグリタゾンを含む医薬組成物 |
EP2618827B1 (en) * | 2010-09-21 | 2021-06-02 | Intekrin Therapeutics, Inc. | Antidiabetic solid pharmaceutical compositions |
FR2966828B1 (fr) * | 2010-11-02 | 2012-12-28 | Roquette Freres | Poudre de polysaccharide et de polyol, comprimable et de haute viscosite |
WO2013034174A1 (en) | 2011-09-06 | 2013-03-14 | ZENTIVA Saglik Ürünleri Sanayi ve Ticaret A.S. | Solid preparations of pioglitazone and glimepiride |
US9592296B2 (en) * | 2011-09-08 | 2017-03-14 | Hexal Ag | Pharmaceutical composition for oral administration with a statin |
AU2012326976B2 (en) | 2011-10-21 | 2017-08-17 | Takeda Pharmaceutical Company Limited | Sustained-release preparation |
US20130158077A1 (en) | 2011-12-19 | 2013-06-20 | Ares Trading S.A. | Pharmaceutical compositions |
US9504679B2 (en) | 2011-12-19 | 2016-11-29 | Bjoern Colin Kahrs | Pharmaceutical compositions comprising glitazones and Nrf2 activators |
CN102641280A (zh) * | 2012-04-23 | 2012-08-22 | 重庆康刻尔制药有限公司 | 一种盐酸吡格列酮格列美脲组合药物、片剂及其应用 |
AU2016229982B2 (en) | 2015-03-09 | 2020-06-18 | Intekrin Therapeutics, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
US20160331689A1 (en) * | 2015-05-12 | 2016-11-17 | SE Tylose USA, Inc. | Aqueous enteric coating composition |
KR101782119B1 (ko) * | 2016-02-01 | 2017-10-23 | 주식회사 한독 | 테넬리글립틴 및 설포닐우레아계 약물을 포함하는 정제 |
EP3606527A1 (en) | 2017-04-03 | 2020-02-12 | Coherus Biosciences, Inc. | Ppar-gamma agonist for treatment of progressive supranuclear palsy |
GB202001237D0 (en) * | 2020-01-29 | 2020-03-11 | Sisteks D O O | Granular pharmaceutical product for oral administration from a pre-filled straw and method of manufacturing such pharmaceutical product |
CN111410687B (zh) * | 2020-02-21 | 2023-06-27 | 成都奥达生物科技有限公司 | 一种长效glp-1化合物 |
CN115721612B (zh) * | 2021-08-26 | 2024-07-26 | 上海宣泰医药科技股份有限公司 | 一种恩扎卢胺固体制剂颗粒及其制备方法 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3152978B2 (ja) | 1991-12-17 | 2001-04-03 | 塩野義製薬株式会社 | 二層錠およびその製造方法 |
TW438587B (en) * | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
US5859037A (en) | 1997-02-19 | 1999-01-12 | Warner-Lambert Company | Sulfonylurea-glitazone combinations for diabetes |
AU8539298A (en) | 1997-06-18 | 1999-01-04 | Smithkline Beecham Plc | Treatment of diabetes with thiazolidinedione and sulphonylurea |
GB9715306D0 (en) | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
TWI257311B (en) * | 1998-07-28 | 2006-07-01 | Takeda Chemical Industries Ltd | Rapidly disintegrable solid preparation |
KR100643833B1 (ko) * | 1998-11-12 | 2006-11-10 | 스미스클라인비이참피이엘시이 | 인슐린 감작제 및 다른 항당뇨병 약제의 개선된 방출을위한 제약 조성물 |
DE60021166T3 (de) | 1999-01-14 | 2019-08-22 | Amylin Pharmaceuticals, Llc | Neue exendin agonist formulierungen und deren verabreichung |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
MY125516A (en) | 1999-11-16 | 2006-08-30 | Smithkline Beecham Plc | Novel composition based on thiazolidinedione and metformin and use |
JP4284017B2 (ja) * | 2000-10-06 | 2009-06-24 | 武田薬品工業株式会社 | 固形製剤 |
AU2001294192A1 (en) * | 2000-10-06 | 2002-04-22 | Takeda Chemical Industries Ltd. | Solid preparations |
RU2177318C1 (ru) | 2000-12-21 | 2001-12-27 | Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" | Фармацевтическая композиция с антидиабетическим действием и способ ее получения |
US20040147584A2 (en) * | 2001-12-05 | 2004-07-29 | Aventis Pharma S.A. | 1,3-diarylprop-2-en-1-ones, compositions containing them and use thereof |
US6682759B2 (en) | 2002-02-01 | 2004-01-27 | Depomed, Inc. | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
WO2004006921A1 (ja) | 2002-07-11 | 2004-01-22 | Takeda Pharmaceutical Company Limited | 被覆製剤の製造法 |
CN1289467C (zh) * | 2002-08-30 | 2006-12-13 | 日本烟草产业株式会社 | 二苄胺化合物及其药物用途 |
UA80991C2 (en) | 2002-10-07 | 2007-11-26 | Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes | |
BRPI0407074A (pt) | 2003-01-29 | 2006-01-24 | Takeda Pharmaceutical | Método para produção de uma preparação revestida, preparação revestida, e, método para melhorar a dissolução do cloridreto de pioglitazona de uma preparação revestida com cloridreto de pioglitazona |
US20040147564A1 (en) | 2003-01-29 | 2004-07-29 | Rao Vinay U. | Combinations of glimepiride and the thiazolidinedione for treatment of diabetes |
WO2004069229A1 (en) * | 2003-02-05 | 2004-08-19 | Ipca Laboratories Limited | Dual release anti-diabetic drugs and process of production thereof |
WO2004091587A1 (en) * | 2003-04-17 | 2004-10-28 | Ipca Laboratories Limited | Multiple release anti-diabetic drugs and process of production thereof |
EP1642593A1 (en) * | 2003-06-06 | 2006-04-05 | Takeda Pharmaceutical Company Limited | Solid pharmaceutical preparation |
EP1638554A1 (en) * | 2003-06-27 | 2006-03-29 | Dr. Reddy's Research Foundation | Compositions comprising balaglitazone and further antidiabetic compounds |
WO2005009407A2 (en) * | 2003-07-29 | 2005-02-03 | Ranbaxy Laboratories Limited | Oral pharmaceutical formulations of olanzapine |
JP4361461B2 (ja) * | 2003-10-31 | 2009-11-11 | 武田薬品工業株式会社 | 固形製剤 |
TWI339586B (en) | 2003-10-31 | 2011-04-01 | Takeda Chemical Industries Ltd | Solid preparation comprising pioglitazone or salt thereof,glimpiride and polyoxyethylene sorbitan fatty acid ester |
EP1738754B1 (en) | 2004-04-14 | 2015-07-15 | Takeda Pharmaceutical Company Limited | Solid pharmaceutical preparation |
WO2005102290A1 (en) * | 2004-04-22 | 2005-11-03 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of a biguanide and a sulfonylurea |
-
2006
- 2006-12-21 BR BRPI0620020-6A patent/BRPI0620020A2/pt not_active IP Right Cessation
- 2006-12-21 EP EP06843549.4A patent/EP1962811B1/en active Active
- 2006-12-21 AR ARP060105709A patent/AR058605A1/es not_active Application Discontinuation
- 2006-12-21 US US12/086,700 patent/US8071130B2/en active Active
- 2006-12-21 CA CA2633149A patent/CA2633149C/en active Active
- 2006-12-21 CN CN200680053318.XA patent/CN101384251B/zh active Active
- 2006-12-21 RU RU2008130074/15A patent/RU2426530C2/ru not_active IP Right Cessation
- 2006-12-21 WO PCT/JP2006/326169 patent/WO2007072992A2/en active Application Filing
- 2006-12-21 AU AU2006328328A patent/AU2006328328B2/en not_active Ceased
- 2006-12-21 MY MYPI20082251A patent/MY149306A/en unknown
- 2006-12-21 NZ NZ569071A patent/NZ569071A/en not_active IP Right Cessation
- 2006-12-21 GE GEAP200610776A patent/GEP20115245B/en unknown
- 2006-12-21 UA UAA200808310A patent/UA91729C2/ru unknown
- 2006-12-21 PE PE2010001114A patent/PE20110019A1/es not_active Application Discontinuation
- 2006-12-21 ZA ZA200805147A patent/ZA200805147B/xx unknown
- 2006-12-21 JP JP2008528691A patent/JP5179363B2/ja active Active
- 2006-12-21 ES ES06843549.4T patent/ES2576258T3/es active Active
- 2006-12-21 TW TW095148113A patent/TWI384985B/zh not_active IP Right Cessation
- 2006-12-21 KR KR1020087014632A patent/KR20080080126A/ko active IP Right Grant
-
2008
- 2008-05-27 IL IL191774A patent/IL191774A0/en unknown
- 2008-05-30 CR CR10032A patent/CR10032A/es not_active Application Discontinuation
- 2008-06-18 MA MA31045A patent/MA30061B1/fr unknown
- 2008-07-10 NO NO20083104A patent/NO20083104L/no not_active Application Discontinuation
-
2016
- 2016-06-14 HR HRP20160679TT patent/HRP20160679T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
US8071130B2 (en) | 2011-12-06 |
CA2633149A1 (en) | 2007-06-28 |
MY149306A (en) | 2013-08-30 |
ES2576258T3 (es) | 2016-07-06 |
AU2006328328A1 (en) | 2007-06-28 |
UA91729C2 (ru) | 2010-08-25 |
IL191774A0 (en) | 2008-12-29 |
JP2009520681A (ja) | 2009-05-28 |
PE20110019A1 (es) | 2011-01-27 |
JP5179363B2 (ja) | 2013-04-10 |
WO2007072992A3 (en) | 2007-12-06 |
CR10032A (es) | 2008-10-03 |
CA2633149C (en) | 2015-06-30 |
CN101384251B (zh) | 2014-09-03 |
MA30061B1 (fr) | 2008-12-01 |
BRPI0620020A2 (pt) | 2011-10-25 |
US20090028939A1 (en) | 2009-01-29 |
KR20080080126A (ko) | 2008-09-02 |
RU2426530C2 (ru) | 2011-08-20 |
GEP20115245B (en) | 2011-06-27 |
NO20083104L (no) | 2008-09-19 |
HRP20160679T1 (hr) | 2016-07-15 |
EP1962811A2 (en) | 2008-09-03 |
TWI384985B (zh) | 2013-02-11 |
ZA200805147B (en) | 2010-05-26 |
AU2006328328B2 (en) | 2012-08-30 |
CN101384251A (zh) | 2009-03-11 |
NZ569071A (en) | 2011-01-28 |
TW200731971A (en) | 2007-09-01 |
EP1962811B1 (en) | 2016-04-27 |
WO2007072992A2 (en) | 2007-06-28 |
RU2008130074A (ru) | 2010-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR058605A1 (es) | Preparacion solida | |
EG25341A (en) | Combinations of pesticidal active substance combinations. | |
WO2009072007A3 (en) | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof | |
CR8713A (es) | Mezclas de pesticidas | |
CR20110110A (es) | Composicion farmaceutica | |
WO2007061939A3 (en) | Metabolite derivatives of the hdac inhibitor fk228 | |
TW200745103A (en) | Substituted 7-azaindazoles, compositions containing them, production process and use | |
CU20080052A7 (es) | Formas de presentación farmacéutica sólidas de administración oral con liberación rápida de principio activo | |
ZA200709169B (en) | Combinations of pesticidal active substance combinations | |
WO2007103719A3 (en) | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | |
TW200633716A (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
WO2008019871A3 (de) | Neue salze des wirkstoffs rasagilin | |
WO2007074454A3 (en) | Stable enzymatic preparations and methods of use thereof | |
PT2222669E (pt) | Derivados de oxadiazole ativos em esfingosina-1-fosfato (s1p) | |
WO2008128775A3 (en) | Stabilised pharmaceutical composition containing pregabaline | |
TNSN07304A1 (en) | Combination of xolair with immunosuppressive agent | |
WO2009066146A3 (en) | Stable solutions of sparingly soluble actives | |
BRPI0620229A8 (pt) | formulação | |
WO2007143651A3 (en) | Chewable co-enzyme q-10 capsule | |
CO6311067A2 (es) | Preparación de comprimido con liberación retardada que contiene polivinilpirrolidonas y principio activo | |
WO2007019272A3 (en) | Method for time based event structure and compliance | |
DK1838315T3 (da) | Substituerede 4-phenyltetrahydroisoquinoliner, fremgangsmåde til fremstilling heraf, deres anvendelse som medikament samt medikamenter indeholdende dem | |
MY165041A (en) | Composition for improving brain function and method for improving brain function | |
TW200640724A (en) | Display for a vehicle | |
UY31452A1 (es) | Recubrimiento mejorado de tableta |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |